Pfizer Delivers Solid Q4 2025 Results, Reaffirms 2026 Guidance as Pipeline Catalysts Multiply
Pfizer reports Q4 revenue of $17.6 billion and full-year 2025 sales of $62.6 billion, with CEO Bourla pointing to 20 pivotal study starts as catalysts for 2026.